Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Staar Surgical Company (NQ: STAA )

46.89 -0.93 (-1.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 350,028
Open 46.90
Bid (Size) 33.00 (1)
Ask (Size) 48.64 (1)
Prev. Close 47.82
Today's Range 45.42 - 47.05
52wk Range 26.66 - 73.13
Shares Outstanding 48,333,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier. 
Via Investor's Business Daily
Star Surgical Shines as U.S. Outlook Improves for 2024
STAAR Surgical is increasing its outlook and guidance as demand for its signature IOL procedure increases with an aging population 
Via MarketBeat

Performance

YTD
+57.72%
+57.72%
1 Month
+30.25%
+30.25%
3 Month
+58.04%
+58.04%
6 Month
+22.62%
+22.62%
1 Year
-30.64%
-30.64%

More News

Read More
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
Via Benzinga
Exposures Product Safety
In-Depth Examination Of 4 Analyst Recommendations For Staar Surgical
Via Benzinga
A Preview Of Staar Surgical's Earnings
Via Benzinga
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive?
Via Investor's Business Daily
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024
From STAAR Surgical Company
Via Business Wire
Nvidia’s Market Cap Myopia: 3 Stocks Proving Size Isn’t Everything
Via InvestorPlace
STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
From STAAR Surgical Company
Via Business Wire
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Exposures Product Safety
Netflix To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
STAAR Surgical to Participate in Two Upcoming Investor Conferences
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision
From STAAR Surgical Company
Via Business Wire
Earnings Scheduled For February 26, 2024
Via Benzinga
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
Via Benzinga
$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023
From STAAR Surgical Company
Via Business Wire
7 Stocks with Strong Insider Buying: December 2023
Via InvestorPlace
Lilian Zhou Appointed to STAAR Surgical Board of Directors
From STAAR Surgical Company
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.